Journal article
First-in-class, first-in-human phase I trial of KPT-330, a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors.
Abstract
2505
Authors
Razak ARA; Soerensen MM; Mahipal A; Shacham S; Yau CYF; Lassen UN; McCauley D; Cooksey J; Tan DSP; Saint-Martin J-R
Journal
Journal of Clinical Oncology, Vol. 31, No. 15_suppl, pp. 2505–2505
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2013
DOI
10.1200/jco.2013.31.15_suppl.2505
ISSN
0732-183X